Abstract

CLC proteins comprise Cl− channels and anion/H+ antiporters involved in several fundamental physiological processes. ClC-7 is a lysosomal Cl−/H+ antiporter that together with its beta subunit Ostm1 has a critical role in the ionic homeostasis of lysosomes and of the osteoclasts’ resorption lacuna, although the specific underlying mechanism has so far remained elusive. Mutations in ClC-7 cause osteopetrosis, but also a form of lysosomal storage disease and neurodegeneration. Interestingly, both loss-of- and gain-of-function mutations of ClC-7 can be pathogenic, but the mechanistic implications of this finding are still unclear. This review will focus on the recent advances in our understanding of the biophysical properties of ClC-7 and of its role in human diseases with a focus on osteopetrosis and neurodegeneration.

Highlights

  • The two ClC-7 subunits are represented in grey and green, the two Ostm1 the membrane plane [6]

  • A detailed electrophysiological characterization recently showed that this mutant does mediate transport currents, their magnitude is strongly reduced compared to WT [41]. This finding potentially explains the phenotype of the E312A knock-in mouse model, as the residual current mediated by the E312A mutant could rescue the pigmentation phenotype and ameliorate the neurodegeneration compared to a full ClC-7 KO

  • Mutations in ClC-7 and Ostm1 can cause both ADO or Autosomal Recessive Osteopetrosis (ARO) [7,10], both characterized by a spectrum of phenotypic presentation that makes the classification quite difficult when no detailed genetic data are available for the affected families [52]

Read more

Summary

Introduction

Human CLC proteins comprise Cl− channels and Cl− /H+ antiporters with fundamental roles in regulating electrical excitability, transepithelial transport and vesicular ionic homeostasis [1,2]. Mutations in ClC-7 and Ostm cause osteopetrosis [7,9,10], and a form of lysosomal storage disease and neurodegeneration [8,15,16], consistent with the phenotype of ClC-7 and Ostm loss-of-function mouse models [7,10]. Viewed from the the hClC-7/Ostm complex based on the work of Schrecker et al (PDB entry 7JM7) viewed from membrane plane [6]. The two ClC-7 subunits are represented in grey and green, the two Ostm the membrane plane [6].

The Structure of ClC-7
The Role of the Proton Glutamate
Transient Capacitive Currents
Osteopetrosis
Location osteopetrosis mutations mutations on of of
The Physiological
Schematic of the
Lysosomal Storage Disease and Neurodegeneration
Findings
Structure–Function Analysis of ClC-7
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.